Company intelligence / Profile preview

Genelabs Medical

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Genelabs Medical is Sri Lanka’s leading private genetic testing laboratory, offering comprehensive molecular diagnostic services including prenatal screening, oncology genetics, infectious disease detection, and academic research support. It was the first private lab in Sri Lanka authorized for COVID‑19 PCR testing and is recognized for introducing advanced tests like NIPT to the country. The company also engages in R&D collaborations with organizations abroad.

Therapeutic areas: OncologyInfectious DiseasesWomen's Health
Modalities: PCR-based diagnosticsNext-generation sequencing diagnosticsSanger sequencing diagnostics
Industry: Molecular Diagnostics

Partnerships

Collaborations with organizations in USA for research projects

Beyond the preview

Go deeper on Genelabs Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genelabs Medical.

Explore the full profile